significant tumour growth inhibition in vivo at well tolerated doses [2].Clinical trial: N
compound.Quercetin is a well-known bioflavonoid and its influence on tumour growth in vivo has been reported.Quercetic
potent anti-T activity and can be used to distinguish between human lymphocyte subsets. PNA has been used in tumour
Studies of SBA-binding normal and tumour cells;Blood group agglutination;Glycoprotein studies;Cell agglutination
in tumorigenesis and correlates with poor prognosis in several tumour types. EPZ005687, a potent inhibitor of EZH2 (K(i
myeloma (MM) therapy given the increased proliferative rates of tumour cells in advanced versus early stages of MM.
and tumour cells. It can initiate cell division (mitogenesis). 0,5-10 μg/ml is required to visibly agglutinate neuraminidase
This tumour suppressor gene is mutated in about half of all human cancers. Recombinant Anti p53 produced in E.Coli
in lung tumours and thus able to counteract harmful tumour-associated proteolytic activity. Human stefin-A & Stef
质谱盛会西安开幕:汇聚全球智慧 共绘质谱新章
美国将37个中国实体列入“黑名单” 含一所高校 多家科研院所
沃特世大刀阔斧谱新章 多款高端液质全面中国造
安益谱“发射”Cassitrap 让每家实验室都能拥有超高分辨质谱
2024年1-4月离子色谱中标盘点,龙头品牌占半壁江山
清谱科技再次完成近亿元A+轮融资,获清控金信投资
第八届华人质谱研讨会 展现科研新趋势
重磅!骆初平出任月旭科技总经理
国产液相色谱龙头依利特再获亿元A+轮融资,年内已获两轮超亿元投资
1-4月气相色谱中标盘点:两家色谱巨头齐头并进 国产占到26%
咨询热线: 010-84839035
联系邮箱: sales@antpedia.net